Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus

M H Rasmussen1, A B Sørensen, D W Morris

  • 1Department of Molecular Biology, University of Aarhus, C. F. Mollers Allé, Building 130, DK-8000 Aarhus C, Denmark.

Virology
|May 26, 2005
PubMed

Insights

Retroviral insertions target the Fos/Jdp2/Batf locus in specific T cell lymphomas, revealing distinct oncogene activation mechanisms. This study highlights the importance of Jdp2 and Batf in distinct retroviral oncogenesis models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Retroviral insertional mutagenesis is a key mechanism in oncogenesis.
  • Jdp2 (Jun dimerization partner 2) activation by Moloney Murine Leukemia Virus (M-MLV) was previously linked to T cell lymphoma in specific mouse models.
  • The role of Jdp2 and related AP-1/ATF family members in other retroviral oncogenesis models remained unclear.

Purpose of the Study:

  • To investigate the role of the Fos/Jdp2/Batf locus in Akv- and SL3-3 Murine Leukemia Virus (MLV)-induced lymphomas.
  • To compare the insertional mutagenesis patterns and oncogenic roles of Jdp2 and Batf in different MLV-induced tumor types.
  • To elucidate the distinct mechanisms of proto-oncogene activation by insertional mutagenesis.

Main Methods:

  • Retroviral tag retrieval and analysis of 1190 Akv- and SL3-3 MLV-induced lymphomas.
  • Integration pattern and clonality analyses.
  • Northern blot analysis and quantitative real-time PCR to assess gene expression and alternative splicing.

Main Results:

  • Insertional mutagenesis within the Fos/Jdp2/Batf locus was significantly associated with SL3-3 MLV-induced T cell lymphomas, but not Akv-induced B cell lymphomas.
  • Integration patterns suggested a distinct role for Jdp2 in SL3-3 MLV tumorigenesis compared to M-MLV.
  • Proviral activation of Batf (Basic leucine zipper transcription factor, ATF-activating transcription factor), a novel target gene, was observed in one tumor.
  • Alternative splicing of Jdp2 was detected in normal tissues and MLV-induced lymphomas, with some tumors showing activation of different mRNA splice variants.

Conclusions:

  • The Fos/Jdp2/Batf locus is a target for insertional mutagenesis in SL3-3 MLV-induced T cell lymphomas, indicating specific oncogenic pathways.
  • Jdp2 and Batf play distinct roles in different MLV-induced oncogenesis models, highlighting context-dependent proto-oncogene activation.
  • Understanding these distinct insertion patterns is crucial for deciphering retroviral activation mechanisms and the specific roles of oncogenes in tumor development.